KA2507 is a potent, orally active and selective HDAC6 inhibitor, with an IC50 of 2.5 nM. KA2507 shows antitumor activities and immune modulatory effects in preclinical models[1].
Molecular Weight:
322.32
Purity:
99.24
CAS Number:
[1636894-46-6]
Formula:
C16H14N6O2
Target:
HDAC
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted